Search This Blog

Monday, March 2, 2026

BioAtla to monetize preclinical and clinical assets, cuts workforce

 

BioAtla to monetize preclinical and clinical assets, cuts workforce ~70% in major restructuring

  • Company initiates a formal process to monetize its preclinical and clinical assets
  • Restructuring includes expanded cost-containment measures alongside approximately 70% workforce reduction

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.